Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 7 signals
Share change
+3,923,288
Put/Call ratio
92%
SEC-reported price per share
$58.48
Number of holders
203
Value change
+$193,923,003
Number of buys
126
Open additional details 1 more signal available
Number of sells
96
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
65,000,000

Security key

09627Y109

Report period

Q1 2020

Institutions

203

Top holders

10

Ownership snapshot

Top reported holders of BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
203
Shares
54,500,343
Rows available
203
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2026 Across Filers

Q1 2026 holders
2
Q1 2020 holders
203
Holder diff
201
Investor Q1 2026 Shares Q1 2020 Shares Share Diff Share Chg % Q1 2026 value Q1 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .